TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LAKHESYS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

LAKHESYS

ST13

US500000079412703

Classe

9, 10, 42, 44

Pedido

79412703

Registro

8200213

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

07/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 10, 42, 44

Data de depósito

28/08/2024

Data de registro

07/04/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

07/04/2026

Última transação

07/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

34

Localização do titular

FR

Examinador

ALBANO, ASHLEY C

Unidade examinadora

L50

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

ASTRAVEUS

Representantes

H. David Starr Muncy, Geissler, Olds & Lowe, P.C.

Classificação técnica

Classes Nice

Classe 9Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Scientific apparatus and instruments for analysis, control and detection of biological and cellular material, namely, combination apparatus consisting of microscopes, spectrometers for laboratory use and microfluidic bioprocessors for laboratory use; microfluidic chips; programmable microfluidic chips; downloadable chemical, biological and cellular analysis software for cell manufacturing; downloadable chemical, biological and cellular database software for cell manufacturing; scientific and laboratory apparatus for pharmaceutical production and bioproduction, namely cell culture incubators for scientific use, bioreactors for cell culturing, and cell culturing vessels for laboratory use; bioreactors for laboratories; laboratory chemical reactors for pharmaceutical production

Classe 10

Medical diagnostic apparatus and instruments for biological and cell analyses; medical diagnostic apparatus and instruments for the detection, analysis and handling of genetic material; genomic analysis apparatus for medical use; medical apparatus and instruments for detecting, analyzing and manipulating biological and cell material for medical use

Classe 42

Biological laboratory services; design, development, installation, maintenance and rental of laboratory apparatus and instruments, namely, microfluidic cell production units, microfluidic bioprocessors and microfluidic cartridges; bioproduction services, namely, biochemical development; culturing and manufacturing cells for scientific research purposes; scientific research in the field of biology, and integrated microfluidic bio-production; biological and cell analysis and manipulation services for scientific use; scientific analysis and retrieval of data in the fields of biology and integrated microfluidic bio-production; computer platform as a service (PaaS) featuring software for cell analysis and manufacturing in the field of biology; design, development, installation, rental and maintenance of computer software in the field of bioproduction and cell production; software as a service (SaaS) featuring software for cell analysis and manufacturing in the field of biology; information services with respect to scientific research by conducting clinical trials

Classe 44

Medical services for biological and cell analysis and manipulation for medical use; medical and health services in biology, namely, provision of health care and medical services by health care professionals; culturing and manufacturing cells for medical therapy purposes, namely, medical treatment of cancer using cultured cells; biological and cell therapy services; medical services for therapy by means of integrated microfluidic bioproduction; information services with respect to biological and cell medical therapies

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/07/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/06/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

18/05/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

18/05/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/04/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/04/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

17/02/2026

PUBO

PUBLISHED FOR OPPOSITION

17/02/2026

GPNX

NOTIFICATION PROCESSED BY IB

12/02/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/02/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

28/01/2026

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

27/01/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/01/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

24/12/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

24/12/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

24/12/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/08/2025

GNFR

FINAL REFUSAL E-MAILED

05/08/2025

CNFR

FINAL REFUSAL WRITTEN

05/08/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/07/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/07/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/07/2025

RFNT

REFUSAL PROCESSED BY IB

09/05/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

24/04/2025

RFRR

REFUSAL PROCESSED BY MPU

24/04/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

14/03/2025

CNRT

NON-FINAL ACTION WRITTEN

13/03/2025

DOCK

ASSIGNED TO EXAMINER

04/03/2025

MAFR

APPLICATION FILING RECEIPT MAILED

20/12/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/12/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

19/12/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LAKHESYS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.